Ocugen, Inc.
OCGN
$1.35
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.58M | 4.47M | 4.41M | 5.37M | 4.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.58M | 4.47M | 4.41M | 5.37M | 4.75M |
| Cost of Revenue | 43.76M | 41.48M | 39.75M | 37.37M | 34.33M |
| Gross Profit | -39.18M | -37.01M | -35.34M | -32.00M | -29.58M |
| SG&A Expenses | 29.72M | 29.24M | 27.58M | 27.76M | 25.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.48M | 70.72M | 67.33M | 65.13M | 60.14M |
| Operating Income | -68.90M | -66.25M | -62.92M | -59.76M | -55.39M |
| Income Before Tax | -81.81M | -71.67M | -67.85M | -64.02M | -56.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -81.81 | -71.67 | -67.85 | -64.02 | -56.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.81M | -71.67M | -67.85M | -64.02M | -56.94M |
| EBIT | -68.90M | -66.25M | -62.92M | -59.76M | -55.39M |
| EBITDA | -66.18M | -62.88M | -59.53M | -56.38M | -52.34M |
| EPS Basic | -0.25 | -0.23 | -0.23 | -0.22 | -0.20 |
| Normalized Basic EPS | -0.15 | -0.14 | -0.14 | -0.14 | -0.12 |
| EPS Diluted | -0.25 | -0.23 | -0.23 | -0.22 | -0.20 |
| Normalized Diluted EPS | -0.15 | -0.14 | -0.14 | -0.14 | -0.12 |
| Average Basic Shares Outstanding | 1.28B | 1.24B | 1.20B | 1.18B | 1.15B |
| Average Diluted Shares Outstanding | 1.28B | 1.24B | 1.20B | 1.18B | 1.15B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |